Unaudited Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Cash flows from operating activities:
Net loss	$ (13,109)	$ (40,028)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	5,738	5,808
Stock-based compensation expense	1,266	1,638
Inventory impairments and option contract abandonments	911	2,246
Deferred and other income tax benefit	(79)	(577)
Changes in allowance for doubtful accounts	(373)	(184)
Equity in income of unconsolidated entities	(302)	(104)
Cash distributions of income from unconsolidated entities	512	336
Loss on extinguishment of debt	153	1,517
Changes in operating assets and liabilities:
Increase in accounts receivable	(6,196)	(287)
Decrease in income tax receivable	0	3,859
Increase in inventory	(156,876)	(40,407)
Decrease in other assets	3,488	2,823
Decrease in trade accounts payable	(11,909)	(7,033)
Decrease in other liabilities	(11,037)	(6,050)
Other changes	(239)	107
Net cash used in operating activities	(188,052)	(76,336)
Cash flows from investing activities:
Capital expenditures	(6,641)	(3,869)
Investments in unconsolidated entities	(3,193)	(400)
Return of capital from unconsolidated entities	0	432
Increases in restricted cash	(2,588)	(1,044)
Decreases in restricted cash	801	7,562
Net cash (used in) provided by investing activities	(11,621)	2,681
Cash flows from financing activities:
Repayment of debt	(4,747)	(183,319)
Proceeds from issuance of new debt	0	200,000
Debt issuance costs	(26)	(4,635)
Settlement of unconsolidated entity debt obligation	0	(500)
Payments for other financing activities	(393)	(26)
Net cash (used in) provided by financing activities	(5,166)	11,520
Decrease in cash and cash equivalents	(204,839)	(62,135)
Cash and cash equivalents at beginning of period	504,459	487,795
Cash and cash equivalents at end of period	$ 299,620	$ 425,660